DAPAGLIFLOZIN IMPROVES PODOCYTES INJURY IN DIABETIC NEPHROPATHY VIA REGULATING CHOLESTEROL BALANCE THROUGH KLF5 TARGETING ABCA1 SIGNALING PATHWAY.
Back
Abstract Number
WCN23-0991
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Diabetic Kidney Disease, Drugs and Treatments
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
DAPAGLIFLOZIN IMPROVES PODOCYTES INJURY IN DIABETIC NEPHROPATHY VIA REGULATING CHOLESTEROL BALANCE THROUGH KLF5 TARGETING ABCA1 SIGNALING PATHWAY.
Co-authors
Wang, Q.(1)*;Zhang, X.(2);Wang, S.(2);Chen, D.(2);Chong, N.(1);Shu, J.(2);Wang, R.(1);Xu, Y.(1);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Shandong Provincial Hospital Affiliated To Shandong First Medical University, Department Of Nephrology, Jinan, China;(2)Shandong Provincial Hospital Affiliated To Shandong University, Department Of Nephrology, Jinan, China;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/bdea6e3b342f75906b2f5468a06f92c9.pdf
Audio File
https://storage.unitedwebnetwork.com/files/1041/9a0ffed2869d6c9ce922bda60306022b.mp3
if any